A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761® in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.
Saved in:
| Title: | A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761® in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol. |
|---|---|
| Authors: | Matias-Guiu JA; Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Universidad Complutense de Madrid, Madrid, Spain., Arelin K; AES Part of Thermo Fisher Scientific, Leipzig, Germany.; MEDIAN Ambulantes Gesundheitszentrum, Leipzig, Germany., Serrano PJ; Thermo Fisher Scientific, Wilmington, NC, United States., Wacker A; Clinical Research, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany., Sória MG; Clinical Research, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany., Burkart M; Global Medical Affairs, Dr. Schwabe Holding SE & Co. KG, Karlsruhe, Germany., Zifko U; Rudolfinerhaus Private Hospital GmbH, Vienna, Austria. |
| Source: | Frontiers in human neuroscience [Front Hum Neurosci] 2026 Jun 15; Vol. 20, pp. 1658342. Date of Electronic Publication: 2026 Jun 15 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477954 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5161 (Print) Linking ISSN: 16625161 NLM ISO Abbreviation: Front Hum Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1662-5161 |
|---|---|
| DOI: | 10.3389/fnhum.2026.1658342 |
